Express Pharma

JUNE 16, 2025

The myasthenia gravis (MG) market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and Japan) is poised to grow at a compound annual growth rate (CAGR) of 5.3 billion in 2024 to $10.3 billion in sales across the 7MM in 2024. per cent from $6.1 billion in 2034, forecasts GlobalData.

Biosimilars 63

Biosimilars Compounding 63

Beckers Hospital Review

JUNE 30, 2025

Forty-one percent have experienced malware or ransomware attacks since early 2024. The challenges are compounded by outdated equipment and software, with many hospitals still using systems like Windows Server 2012 and non-upgradable EHRs.

Hospitals 97

Hospitals HIPAA Compounding 97

Express Pharma

JULY 8, 2025

The pulmonary arterial hypertension (PAH) market across the seven major markets (7MM*) is poised to grow at a compound annual growth rate (CAGR) of 2.0 billion in 2024 to $9.3 per cent of global sales in 2024 ($5.8 per cent from $7.6 billion), and is expected to gain further market value during the forecast period, reaching $7.0

Compounding 103

Compounding 103

vizient

AUGUST 20, 2024

expert will moderate a panel discussion at the 2024 Compounding Quality Center of Excellence Annual Conference, hosted by the Food and Drug Administration from August 21-23. A Vizient, Inc.

Compounding 59

Compounding 59

Pharmaceutical Technology

JUNE 26, 2025

Indeed, in 2024, the Nobel Prize in Chemistry was awarded to the DeepMind team for their work on AlphaFold [ii] , an AI system that accurately predicts protein structures. AI models can predict molecular interactions and assist in designing novel compounds tailored to specific therapeutic goals.

Compounding 86

Compounding Drug Development Communication Packaging 86

Express Pharma

JULY 29, 2024

Sionna Therapeutics, a US-based clinical-stage life sciences company specialising in cystic fibrosis (CF), has secured exclusive global rights to develop and commercialise multiple advanced compounds through a licence agreement with AbbVie. The strategic implications of this agreement are substantial.

Compounding 103

Compounding 103

Express Pharma

DECEMBER 13, 2024

According to GlobalDatas latest report, Market and Opportunity Forecast to 2028, Data and Analytics 2024, the total global data and analytics market is forecast to increase at a compound annual growth rate (CAGR) of 9.5 The global data and analytics market in the pharmaceutical sector was valued at $1.1

Compounding 105

Compounding 105

FDA Law Blog: Biosimilars

FEBRUARY 2, 2025

By Sara M Keup In reviewing some new 2025 pharmacy rules/laws a couple interesting changes caught this bloggers attention: As of December 30, 2024, Missouri has rolled out new rules related to prescription drug delivery requirements. The California Board of Pharmacy updated many of the application forms and guidelines in late 2024.

Packaging 59

Packaging Documentation Compounding 59

Pharmaceutical Technology

MAY 2, 2025

The post-traumatic stress disorder (PTSD) market is expected to grow at a high compound annual growth rate of 16.1%

Compounding 69

Compounding 69

European Pharmaceutical Review

NOVEMBER 25, 2024

The market is furthermore expected to see a compound annual growth rate (CAGR) of 7.3 percent between 2024 and 2032. percent market share between 2024 and 2032, based on the forecast by Straits Research. Their analysis projected that the market will exceed a value of $15.46 billion by 2032.

Drug Development 52

Drug Development Biosimilars Compounding Pharmaceutical Companies 52

Express Pharma

MARCH 25, 2025

The global cell and gene therapy (CGT) market is poised for exceptional growth at a compound annual growth rate of 44 per cent, with sales projected to rise from $8.70 billion in 2024 to $76.03 billion in 2030.

Compounding 63

Compounding 63

Pharmaceutical Technology

JUNE 24, 2025

Robert Barrie June 24, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Compounded GLP-1RA medication has become a key revenue driver for Hims & Hers’ telehealth platform. Hims & Hers’ revenue has been soaring on the back of its compounded glucagon-like peptide-1 receptor agonist (GLP-1RA) sales.

Compounding 52

Compounding Packaging Online Pharmacies Communication 52

Pharmaceutical Technology

JUNE 30, 2025

The chronic kidney disease (CKD) anemia market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and Japan) is poised to grow at a compound annual growth rate (CAGR) of 1.7%

Compounding 52

Compounding 52

Pharmacy Times

DECEMBER 24, 2024

Despite the explosion of public interest in these drugs, ongoing shortages and debates over compounding made access difficult.

Compounding 55

Compounding 55

Pharmaceutical Technology

AUGUST 27, 2024

OUD is a chronic neurological disorder described as the consequences associated with repeated, compulsive use of opioid drugs.

Compounding 52

Compounding 52

Express Pharma

MARCH 25, 2024

The agreement includes Cardior’s lead compound CDR132L, currently in phase 2 clinical development for the treatment of heart failure. The closing of the acquisition is subject to receipt of applicable regulatory approvals and other customary conditions and is expected to happen in the second quarter of 2024.

Compounding 110

Compounding Communication 110

European Pharmaceutical Review

AUGUST 3, 2023

EPC’s new Cannabis flower monograph The new monograph Cannabis flower (Cannabis flower, monograph 3028) will be available next year in January 2024 with publication of the supplement 11.5. The monograph will enter into force several months later, in July 2024. 1 July 2024).

Compounding 98

Compounding Pharmaceutical Companies Pharmaceutical Companies 98

Digital Pharmacist

DECEMBER 22, 2023

Recognizing and addressing these changing dynamics is crucial as we step into 2024. Digital Transformations As in the past years, one of the top pharmacy trends of 2024 remains to be “digital.” The post 2024 Pharmacy Trends to Look For appeared first on Digital Pharmacist.

Community Pharmacies 52

Community Pharmacies Prescription Filling Medication Delivery Packaging 52

Express Pharma

JANUARY 14, 2025

per cent from 2024 to 2030. billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.3 billion in 2023 and is expected to grow at a CAGR of 8.4 Whereas the global vitamin supplements market size was estimated at $48.51 per cent from 2023 to 2030.

Diabetes 105

Diabetes Compounding 105

European Pharmaceutical Review

NOVEMBER 27, 2023

The compound has a similar function to an antibody, binding and neutralising harmful fAABs. Long COVID drug candidate BC 007 As a platform technology, BC 007 has the potential to cure different autoimmune diseases by targeting fAABs as their root cause, Berlin Cures stated.

Compounding 130

Compounding 130

RX Note

JUNE 8, 2025

Expiry dates guidance aligned with the United States Pharmacopeia. Given that public healthcare is centrally provided by government hospitals and clinics, prescribing practices are guided by the Ministry of Health Medicines Formulary and local formularies.

Compounding 40

Compounding Hospitals Patient Counseling Labelling 40

PharmaTech

OCTOBER 25, 2024

The laboratory is on the same site as BioDuro-Sundia’s new Compound Management Center, which was launched earlier in October 2024.

Compounding 59

Compounding 59

PharmaTech

JANUARY 13, 2025

This is the latest facility launch for BioDuro, following a kilogram laboratory and compound management center, both on the same site, in October 2024.

Compounding 59

Compounding 59

European Pharmaceutical Review

NOVEMBER 21, 2024

What psychedelic compounds have shown the most promise or are better suited for certain conditions? Each of the compounds has unique properties and may be better suited for certain conditions. The willingness of federal institutes to fund and support studies in psychedelics is a big shift in acceptance. Internet] US FDA.

Compounding 97

Compounding Documentation 97

PharmaTech

JUNE 10, 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines Feliza Mirasol April 30th 2024 Podcast In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Vaccines 85

Vaccines Insurance Coverage and Processing Dosage Drug Development 85

European Pharmaceutical Review

MARCH 15, 2024

The market is set to witness a compound annual growth rate (CAGR) of 9.7 percent of the market share in 2024, the report stated. percent of the market share in 2024. According to research published by Coherent Market Insights, the global mycoplasma testing market is anticipated to reach $1,907.6 million by 2031.

Compounding 98

Compounding 98

Pharmacy Is Right For Me

JULY 23, 2024

This camp gave me a real taste of what being a pharmacist entails as I compounded medications and completed various patient care simulations. One easy way to visit many pharmacy schools from the comfort of your own home is to attend the Virtual Pharmacy School Fair on September 25, 2024 from 10am – 5pm EST! Register today!

Compounding 246

Compounding Hospitals 246

The Happy PharmD

NOVEMBER 19, 2024

Pharmacies are closing at an alarming rate in 2024, and the consequences are shaking the very foundation of healthcare in this country. This lack of interest could lead to a staffing shortage in the future, further compounding the challenges in pharmacy. But it’s not all doom and gloom.

Mail-Order Pharmacies 52

Mail-Order Pharmacies Independent Pharmacies Compounding Hospitals 52

Express Pharma

JULY 4, 2025

The endometriosis market across the seven major markets (7MM*) is forecast to increase at a compound annual growth rate (CAGR) of 10.3 million in 2024 to $2.5 per cent from $938.0 billion in 2034, forecasts GlobalData.

Labelling 93

Labelling Compounding 93

European Pharmaceutical Review

OCTOBER 25, 2024

The compound was designed to address issues such as payload toxicity seen in first-generation ADC therapies, according to Zai Lab. This initial data on ZL-1310 was presented this week at the EORTC-NCI-AACR (ENA) Symposium 2024. ZL-1310 is humanised anti-DLL3 monoclonal antibody with a topoisomerase 1 inhibitor payload.

Chemotherapy 97

Chemotherapy Compounding Immunization Immunity 97

European Pharmaceutical Review

NOVEMBER 28, 2024

Undefined terms like “undue delay” and “disproportionate effort” add layers of uncertainty, which are further compounded by the fact that enforcement will rely on varying capacities and interpretations, as the EU relies on 27 independent data protection authorities 3 to enforce regulations.

Documentation 105

Documentation Compounding 105

pharmacy mentor

JUNE 16, 2025

billion in 2022, and forecasts indicate it will expand at a compound annual growth rate (CAGR) of 20.4% By 2024, Fortune Business Insights estimated the market had already doubled to USD 127.95 A Global Surge: Online Pharmacies on the Rise The global ePharmacy market was valued at approximately USD 60.0 billion by 2032.

Online Pharmacies 52

Online Pharmacies Customer Service People Management Packaging 52

pharmaphorum

AUGUST 2, 2022

The potential for ADCs to combine the best of both mAbs and small molecule drugs means that there has been high interest in developing a successful compound since the first successful clinical trial in 1983. Development of the compound was subsequently ended. billion in revenue last year. Not all rosy.

Compounding 98

Compounding Drug Development 98

Pharmaceutical Business Review

OCTOBER 24, 2024

The CRL, dated 22 October 2024, comes ahead of the Generic Drug User Fee Amendments of 2022 (GDUFA) goal date set for 29 October 2024. Ketamine, an essential medicine for anaesthesia and analgesia, is listed on the WHO Essential Medicines List and approved by Health Canada for use as a sedative and painkiller in hospitals.

Compounding 52

Compounding Hospitals 52

Express Pharma

JANUARY 11, 2024

The sales growth of gout therapies across the seven major markets (7MM: the US, 5EU, and Japan) is set to increase at a compound annual growth rate (CAGR) of 8.8 With Ilaris’ US patent expiring in 2024, this biosimilar is anticipated to enter the market and potentially diminish Ilaris’ share. per cent from $4.6

Biosimilars 103

Biosimilars Compounding 103

pharmaphorum

JUNE 12, 2025

These closures, compounded by the decline of independent pharmacies, create a critical gap in care. For example, per capita out-of-pocket prescription drug spending is projected to grow from $175 in 2024 to $227 by 2032, a 3.3% These closures put medication access, affordability, and adherence at greater risk. annual increase.

Health and Personal Care Stores 59

Health and Personal Care Stores Diabetes Pharmaceutical Companies Pharmaceutical Companies 59

European Pharmaceutical Review

APRIL 25, 2024

Four key barriers to female career progression were explored during a panel at the UK 2024 Advanced Therapies conference in March. Jones summarised how a lack of confidence can be compounded in the cell and gene therapy sector, given it is such a changing industry: “often you are out of your comfort zone”. cited 2024Apr].

Compounding 105

Compounding 105